首页 | 本学科首页   官方微博 | 高级检索  
     


Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs
Authors:Oikonomakos Nikos G  Kosmopoulou Magda N  Chrysina Evangelia D  Leonidas Demetres D  Kostas Ioannis D  Wendt K Ulrich  Klabunde Thomas  Defossa Elisabeth
Affiliation:Institute of Organic and Pharmaceutical Chemistry, The National Hellenic Research Foundation, Athens, Greece. ngo@eie.gr
Abstract:Acyl ureas were discovered as a novel class of inhibitors for glycogen phosphorylase, a molecular target to control hyperglycemia in type 2 diabetics. This series is exemplified by 6-{2,6-Dichloro- 4-[3-(2-chloro-benzoyl)-ureido]-phenoxy}-hexanoic acid, which inhibits human liver glycogen phosphorylase a with an IC(50) of 2.0 microM. Here we analyze four crystal structures of acyl urea derivatives in complex with rabbit muscle glycogen phosphorylase b to elucidate the mechanism of inhibition of these inhibitors. The structures were determined and refined to 2.26 Angstroms resolution and demonstrate that the inhibitors bind at the allosteric activator site, where the physiological activator AMP binds. Acyl ureas induce conformational changes in the vicinity of the allosteric site. Our findings suggest that acyl ureas inhibit glycogen phosphorylase by direct inhibition of AMP binding and by indirect inhibition of substrate binding through stabilization of the T' state.
Keywords:type 2 diabetes   glycogen phosphorylase   acyl ureas   inhibition   X-ray crystallography
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号